Open Access

Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance

  • Authors:
    • Jing Pan
    • Yuanyuan Sun
    • Ning Zhang
    • Jianming Li
    • Fangxin Ta
    • Wei Wei
    • Shanshan Yu
    • Limei Ai
  • View Affiliations

  • Published online on: July 7, 2017     https://doi.org/10.3892/ol.2017.6528
  • Pages: 2657-2662
  • Copyright: © Pan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The characteristics of the proliferation of B-cell activating factor (BAFF) and the proliferation-inducing ligand (APRIL) mRNA expression in mononuclear cell in multiple myeloma patients were detected, and the correlation was analyzed between the BAFF and APRIL concentrations in plasma and tumor burden parameters of multiple myeloma. Bone marrow samples from 60 patients with multiple myeloma and 20 healthy persons taken as controls, were collected. Bone marrow mononuclear cells (BMMCs) were harvested, and plasma was extracted. BAFF and APRIL mRNA expression was quantified using real-time fluorescent quantitative PCR in the BMMCs. ELISA was used to detect the characteristics of gene and protein expression of BAFF and APRIL in KM3 cell line. The BAFF and APRIL mRNA expression in initial treatment group, remission group and non-remission group were markedly higher than that in control group (P<0.05). The expression in initial treatment group and non‑remission group was markedly higher than that of the control group (P<0.05). APRIL mRNA expression in mononuclear cells in stage Ⅲ patients was markedly higher than that in stage Ⅱ patients (P<0.05). There was positive correlation between APRIL and BAFF concentration in multiple myeloma (P=0.0027). In conclusion, for the gene and protein expression of BAFF and APRIL in patients with multiple myeloma, the initial treatment group and non-remission are higher than control and remission group. The higher the stage was, the more the factors were expressed. Characteristics of expression of BAFF and APRIL may be used as a new index to evaluate the prognosis of multiple myeloma.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 14 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Pan J, Sun Y, Zhang N, Li J, Ta F, Wei W, Yu S and Ai L: Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance. Oncol Lett 14: 2657-2662, 2017
APA
Pan, J., Sun, Y., Zhang, N., Li, J., Ta, F., Wei, W. ... Ai, L. (2017). Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance. Oncology Letters, 14, 2657-2662. https://doi.org/10.3892/ol.2017.6528
MLA
Pan, J., Sun, Y., Zhang, N., Li, J., Ta, F., Wei, W., Yu, S., Ai, L."Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance". Oncology Letters 14.3 (2017): 2657-2662.
Chicago
Pan, J., Sun, Y., Zhang, N., Li, J., Ta, F., Wei, W., Yu, S., Ai, L."Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance". Oncology Letters 14, no. 3 (2017): 2657-2662. https://doi.org/10.3892/ol.2017.6528